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Cellular transformationThe pleiotropic HBx oncoprotein of hepatitis B virus is well known to promote the expression of ribosomal RNAs
and several host proteins that are known to support the development and progression of hepatocellular
carcinoma (HCC). While overexpression of the nucleolar phosphoprotein, nucleophosmin (NPM), correlates
with HCC progression, its upregulation by viral HBx and the resulting impact on perturbed nucleolar functions
remain enigmatic. The present study shows that HBx up-regulates NPM levels and hijacks its functions to
promote cellular proliferation. We found that HBx expression stabilizes NPM through post-translational modiﬁ-
cations. Enhanced CDK2-mediated phosphorylation of NPM at Thr199 upon HBx expression prevented its
proteolytic cleavage and provided resistance to apoptosis. Further, HBx directly interacted with the C-terminal
domain of NPM and got translocated into the nucleolus where it facilitated the recruitment of RNA polymerase
I transcriptional machinery onto the rDNA promoter. Our results indicate that HBx enhances rDNA transcription
via a novel regulatory mechanism involving acetylation of NPM and the subsequent depletion of histones from
the rDNA promoter. Enhanced production of ribosomal RNA resulting from co-expression of HBx and NPM
promoted ribosome biogenesis, cellular proliferation and transformation. Taken together, our study strongly
suggests an important role of NPM in mediating the oncogenic effects of HBx and the corresponding nucleolar
perturbations induced by this viral oncoprotein.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
In eukaryotes, ribosomebiogenesis is an extraordinarily orchestrated
multistep process requiring the coordinated action of all three RNA
polymerases and involving the assembly of ribosomal RNAs (rRNAs)
and ribosomal proteins (RPs) [2,54]. After their synthesis in the
cytoplasm, RPs are translocated into the nucleolus where along with
rRNAs they are assembled into two ribosomal subunits. The rRNA
synthesis and nucleolar import of RPs involve a complex interplay of
several factors including the multifunctional nucleolar phosphoprotein,
nucleophosmin (NPM). NPM is a ubiquitously expressed nucleolar
protein that shuttles across different cellular compartments primarily
due to the presence of nuclear localization, nucleolar localization and
nuclear export signals [15]. It affects diverse cellular processes such as
DNA replication and repair, transcription, chromatin remodeling,hromatin immunoprecipitation;
cellular carcinoma; IHH, immor-
, maltose binding protein; MBP-
R, polymerase chain reaction;
real-time quantitative PCR; WB,
91 11 26742316.apoptosis, formation of mitotic spindle and centrosome duplication
[37]. NPM also plays a lead role in ribosome biogenesis by engaging c-
Myc to stimulate RNA Pol I-dependent transcription [35] and by
exporting ribosomal proteins and mature ribosomes from nucleolus to
the cytoplasm [4,39,60]. Besides, NPM may undergo several post-
translational modiﬁcations such as phosphorylation, acetylation, and
SUMOylation which affect its functions [38,45,51]. For example, the de-
regulation of NPM phosphorylationmay result in the formation of super-
numerary centrosomes and missegregation of chromosomes leading to
aneuploidy [12,28,44]. These changes are considered as hallmarks of
many cancers [18].
Enhanced expression of NPM is associatedwithuncontrolled cellular
proliferation and neoplastic transformation [9,15,16]. Most of the
human cancers including hepatocellular carcinoma (HCC) are charac-
terized by nucleolar hypertrophy and increased ribosome biogenesis
[56]. TheHBx oncoprotein of hepatitis B virus (HBV)which is implicated
in the development of HCC, is also known to stimulate RNA polymerase
I-dependent promoters and upregulate rRNA synthesis and ribosome
biogenesis [49]. However, the molecular mechanisms underlying the
activation of rDNA transcription by HBx remain to be elucidated.
Since, HCC patients with HBV infection show a strong positive correla-
tion between elevated NPM levels and poor prognosis [61], NPM could
serve as a potential link between increased production of ribosomes
and progression of HBV-mediated HCC.
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and cellular NPM.We report a direct interaction between HBx and NPM
which was associated with the stabilization of NPM and nucleolar
accumulation of the viral oncoprotein. The nucleolar HBx facilitated
nucleosome disassembly at the rDNA promoter and stimulated rRNA
synthesis in an NPM-dependent manner. Thus, the present study
shows how a viral oncoprotein can subjugate NPM functions in order
to control ribosome biogenesis and induce cancer phenotype.
2. Materials and methods
2.1. Expression plasmids, shRNA and reporter constructs
Eukaryotic expression vectors forwild type HBx and its deletionmu-
tant, X9 have been described previously [30]. FLAG-tagged WT-NPM
and its mutants were kindly provided by Prof. Charles Sherr [3,31].
His-NPM prokaryotic construct was developed by cloningWT–NPM se-
quence at EcoRI–XhoI restriction sites in pET28a. HBx-speciﬁc shRNA
(XE) [22], MBP–HBx [50] and luciferase reporter construct rDNA-pGL3
[49] have been previously reported.
2.2. Cell culture and DNA transfection
Human hepatoma Huh7 cells (kindly provided by Dr. Aleem
Siddiqui, University of Colorado, Denver), Immortalized Human
Hepatocytes (IHH; kindly provided by F. Danniel), Human liver carcino-
ma HepG2 (ATCC HB-8065) and its derivative HepG2.2.15 cells (a kind
gift from Dr. S. Kamili, CDC, Atlanta) were maintained in Dulbecco's
modiﬁed Eagle's medium (DMEM) (Invitrogen, USA) supplemented
with 10% fetal bovine serum (FBS) and penicillin/streptomycin
(100 μg/ml) at 37 °C in a humidiﬁed atmosphere with 10% CO2. Cells
in 60-mm (0.6 × 106 cells) and 100-mm (0.8 × 106 cells) culture dishes
were transfected respectively with 2 and 5 μg of indicated plasmids
using Lipofectamine (Invitrogen, USA) according to manufacturer's
protocol. For luciferase reporter assays, 0.5 μg of luciferase reporter
construct was co-transfected with 1.5 μg of the indicated expression
plasmids in 6-well culture plates (0.4 × 106 cells/well).
2.3. Chemical reagents and antibodies
The chemical inhibitors MG132 (40 μM for 6 h), cycloheximide
(100 μg/ml for 15 min) and CDK2 inhibitor II (10 μM for 6 h) were
obtained from Calbiochem (EMD Biosciences, USA). Thymidine
(Sigma-Aldrich, St. Louis, MO) was used at a concentration of 2 mM
for 10–12 h. Etoposide (Sigma-Aldrich) was used at a concentration of
50 μM for 24–48 h. Antibodies against NPM (B23), UBF, HBx, ubiquitin,
c-Myc, HA-epitope, Rb, pRb (Ser807) and GAPDH were obtained from
Santa Cruz Biotechnology (Santa Cruz, CA, USA). Antibodies against
pNPM (Thr199) and RNA polymerase I were procured from Abcam
(Cambridge, MA, USA). Mouse antibody against FLAG-tag was obtained
from Sigma. ChIP grade antibodies against total and acetylated histones
were procured from EMD Millipore (Billerica, Massachusetts, USA).
Other chemical reagents used were 4′,6-diamidino-2-phenylindole
(DAPI, Molecular probes, Invitrogen, USA), 3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide (MTT) and Heparin (Sigma-Al-
drich), Luciferase assay system (Promega, Madison, WI), Moloney Mu-
rine Leukemia Virus Reverse Transcriptase (Fermentas, Waltham, MA,
USA), SYBR Green Mix (Bio-Rad, USA). All the restriction enzymes used
were from Fermentas.
2.4. Immunoprecipitation and western blotting
Western Blotting (WB) and immunoprecipitation (IP) for protein
samples were done as described previously [41].2.5. RNA isolation and quantitative reverse transcription PCR (RT-qPCR)
Total RNA was isolated from cells using TRIzol reagent (Invitrogen)
following manufacturer's instructions. cDNA was prepared using either
random hexamer (for rRNA) or oligo-dT primer (for mRNA) as de-
scribed earlier [49]. RT-qPCR was performed using SYBR Green mix on
StepOnePlus platform (Applied Biosystems, Foster City, California,
USA) as described previously [23] with speciﬁc primers (Supplemental
Table S1). The results were analyzed using the comparative CT method
[47].
2.6. Chromatin immunoprecipitation (ChIP) assay
ChIP assay was performed as described previously [52]. The eluted
chromatin was analyzed either by semi-quantitative PCR or SYBR green
based real-time qPCR with the indicated primer sets (Supplemental
Table S1). For all ChIP assays, cells were serum-starved for 60 h and
harvested after 9 h of serum stimulation.
2.7. Luciferase assay
Luciferase assay was performed using luciferase assay system
(Promega) as per manufacturer's instructions. Relative luciferase activity
was calculated after normalizing with total protein in the samples. The
results are expressed as mean ±SD of three independent experiments.
2.8. Cell synchronization and ﬂuorescence-activated cell sorting (FACS)
Huh7 cells were synchronized by double thymidine block (2 mM)
after 24 h of transfection as reported previously [46]. Treated cells
were harvested, ﬁxed and stained with propidium iodide (50 μg/ml)
[29] and ﬂow cytometry was performed using FACSCalibur (Becton,
Dickinson and Company, New Jersey, USA). Cell cycle analysis was
done using FlowJo software version 4.5.4.
2.9. X15-myc transgenic mouse model
The development of X15-myc transgenic mouse model of HCC has been
reportedearlier [32]. Liver tissue samplesof control and transgenicmiceof in-
dicated age groups were collected and processed for western blotting [23].
2.10. In vitro protein–protein interaction study
Recombinant MBP and MBP–HBx fusion proteins were expressed
and puriﬁed as described previously [50]. The recombinant His-NPM
protein was expressed using pET-28a vector and was afﬁnity puriﬁed
withNi–NTA resin. PuriﬁedHis-NPMproteinwas dialyzed against bind-
ing buffer (1× PBS, 0.4% Triton X-100 and protease inhibitor cocktail).
For each assay, 50 μg of puriﬁed His-NPM was incubated with 50 μl
bed volume of Ni–NTA Superﬂow resin (Qiagen, Limburg,
Netherlands) in binding buffer at 4 °C for 2 h after which the beads
were washed thrice with binding buffer. Beads were then incubated
with either 10 μg MBP or MBP–HBx in 2 ml binding buffer for 16 h at
4 °C. Finally, beads were washed 5 times with 1 ml binding buffer and
the bound proteins were eluted by boiling the beads in 2× Laemmli
buffer. The samples were resolved by SDS-PAGE followed either by
staining with Coomassie brilliant blue or by immunoblotting with α-
HBx or α-NPM antibodies.
2.11. Immunoﬂuorescence assay
Huh7 cells were seeded on coverslips in a 12-well plate
(0.1 × 106 cells/well) and transfected with indicated expression
plasmids. After 48 h, cells were processed for immunoﬂuorescence
assay as described previously [13]. Fluorescent Alexa Fluor 488 and
594 conjugated secondary antibodies (Molecular probes, USA) were
1785R. Ahuja et al. / Biochimica et Biophysica Acta 1853 (2015) 1783–1795used. The coverslips were mounted on glass slides with DAPI anti-fade
solution to visualize the nucleus. The images were captured with a
×60 objective with NIKON A1R confocal microscope (Nikon, Japan).
2.12. Cell viability assay
IHH cells seeded in 6-well plates were transfected with indicated
plasmids. 24 h post-transfection, cells were treated with 50 μM
etoposide for 48 h following which the cells were processed for MTT
assay to determine the viability of cells as described earlier [6].
2.13. Ribosome proﬁling
Ribosome proﬁlingwas carried out as described previously [17]with
some modiﬁcations. Brieﬂy, Huh7 cells were transfected with indicated
expression plasmids andwere incubatedwith 100 μg/ml cycloheximide
for 15 min prior to harvesting. The cells were lysed by resuspension in
polysome extraction buffer (20 mm Tris–HCl pH 7.5, 50 mm KCl,
10mmMgCl2, 1 mMDTT, 100 μg/ml Heparin, 1% Triton X-100 and pro-
tease inhibitor cocktail) followed by vortexing. After incubation on ice
for 1 h, the lysates were centrifuged at 14,000 rpm for 15 min at 4 °C
and the supernatants were collected. The sampleswere then fractionat-
ed on sucrose gradients of 10–50% consistency followed by centrifuga-
tion at 38,000 rpm for 2 h at 4 °C. Fractions were collected followed by
spectrophotometry at 254 nm.
2.14. Colony formation assay
IHH cells transfected with indicated expression vectors were
trypsinized 48 h post-transfection and soft agar colony formation
assay was performed as described earlier [26]. Bright ﬁeld images of
colonies formedwere captured with a ×10 objective with Nikon Eclipse
Ti inverted microscope (Nikon, Japan). The number of colonies formed
were counted and their mean (n = 3) was determined.Fig. 1. Effect of HBx on NPM expression. (A) Huh7 and IHH cells were transfectedwith the vecto
western blotting. (B) NPM protein levelsmeasured as above in HepG2 and HepG2.2.15 cells. GA
transgenic mice model of different age groups (3 months and 9 months) were immunoblotted
independent experiments. Relative expression levels of NPM protein are shown below the corr
plasmidwere synchronized by double thymidine block. The cell lysateswere collected at the ind
mean relative levels of NPM obtained from three independent experiments after normalization2.15. Statistical analysis
Statistical signiﬁcance of the results was tested by one-way ANOVA
(Analysis of variance) followed by post-hoc comparisons using Tukey's
HSD (honestly signiﬁcant difference) test using Sigma plot 12.0 (www.
sigmaplot.com). Quantitative data obtained fromdensitometric analysis
of western blots and Coomassie stained SDS-PAGE gels are shown as
mean ± standard deviation of three independent experiments along
with their p-values in supplemental Table S2. Data were considered sig-
niﬁcant at p b 0.05 (*), p b 0.01 (**) and highly signiﬁcant at p b 0.001
(***).
3. Results
3.1. HBx modulates NPM expression during the S phase of cell cycle
AsNPM level is known to be upregulated inmanyhuman cancers in-
cluding HCC, we wondered if a viral oncoprotein like HBx could induce
NPM expression in the hepatic microenvironment. The level of NPM
was measured after transfecting human hepatoma Huh7 cells and im-
mortalized human hepatocytes (IHH) cells with the HBx expression
vector. NPM protein levels were found to be upregulated in the
presence of HBx (Fig. 1A). Concurrently, a marked increase in the NPM
protein level was also observed in HepG2.2.15 cells (Fig. 1B) that carry
the HBV genome integrated into the human hepatoma HepG2 cells
and express HBx protein [48]. Consistent with these observations,
nearly 3–5 fold increase in the NPM protein levels was also observed
in the liver tissues of three and nine months old X15-myc transgenic
mouse model of HCC (Fig. 1C). No appreciable change in the levels of
NPM transcript was seen under these conditions (Supplemental Fig. S1).
As NPM is majorly required during the replicative (S) and mitotic
(M) phases of the cell cycle [37,44], we next analyzed the effect of
HBx on NPM expression during different phases of the cell cycle. Huh7
cells synchronized at the G1/S transition using double thymidine blockr control (V) or HBx expression plasmid and the levels of NPM protein were measured by
PDHwas used as an internal control. (C) Liver tissue lysates from the control and X15-myc
for NPM. Actin was used as a loading control. The blots shown are representative of three
esponding panels. (D) Huh7 cells transfected with either vector control or HBx expression
icated time points after release and immunoblotted for NPMandGAPDH. Graph shows the
with GAPDH. Error bars represent ± standard deviation (S.D.); n = 3.
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HBx particularly during the S-phase, whereas the expression was
maintained at a basal level during other phases of cell cycle (Fig. 1D,
Supplemental Fig. S2A and S2B).
3.2. HBx stabilizes NPM by enhancing its phosphorylation
Since HBx is reported to potentiate the activity of CDK2 kinase [41]
which phosphorylates NPM at Thr199[55], we next monitored the
phosphorylation status of NPM in its presence. We found a marked
increase in the phosphorylation of NPM at Thr199 in the presence of
wild-type HBx in contrast to its mitogenic signaling domain mutant
X9 [41], which failed to induce the phosphorylation (Fig. 2A and
Supplemental Fig. S3). Since, the total NPM protein level also in-
creased upon HBx expression, we wondered if CDK2-mediated NPMFig. 2. Phosphorylation and stability of NPM in the presence of HBx. (A) IHH cells were transfec
and the levels of total, phosphorylated and cleavedNPMweremeasuredbywestern blotting. (B
the cellswere harvested 6 h post-treatment. Protein levels of total, cleaved and Thr199 phosphor
total, cleaved and phosphorylated NPMunder different conditions are shown below the corresp
(C) Interaction of caspase-3 and NPM. Lysates of IHH cells transfected with either vector contro
immunoblotted for NPM and caspase-3. (D) Interaction of caspase-3 and NPM in the pres
immunoprecipitated with anti-caspase-3 antibody and immunoblotted for caspase-3, phosph
The blots shown are representative of three independent experiments.phosphorylation at Thr199 has any role in promoting the intracellular
stability of NPM. The stability of NPM is well known to be regulated
via its cleavage by caspase-3 [7]. Therefore,wemonitored the proteolyt-
ic cleavage of NPM under these conditions. We found a strong negative
correlation between Thr199 phosphorylation of NPM and its cleavage as
increase in phosphorylation of NPM at Thr199 in the presence of HBx
decreased the amount of 21 kDa cleaved form of NPM (Fig. 2A). On
the other hand, mutant X9 that does not potentiate CDK2 activity, failed
to confer intracellular stability to NPM (Fig. 2A and Supplemental
Fig. S3).
To establish the role of CDK2 in NPM stabilization, HepG2 and
HepG2.2.15 cells were treated with CDK2 inhibitor and the levels of
Thr199 phosphorylated, full length and proteolytically cleaved forms of
NPMweremeasured. Treatmentwith CDK2 inhibitor led to a signiﬁcant
decline in the levels of full length NPM with a concomitant increase intedwith either vector control (V), wild-type HBx expression vector (HBx) or its mutant X9
)HepG2 andHepG2.2.15 cellswere treatedwith CDK2 inhibitor II (10 μM,Calbiochem) and
ylatedNPMwere analyzedby SDS-PAGE andwestern blotting. Relative expression levels of
onding panels. Phosphorylated Rbwas used as a control for the inhibition of CDK2 activity.
l or HBx expression plasmid were immunoprecipitated with anti-caspase-3 antibody and
ence or absence of CDK2 inhibitor in HBx-transfected IHH cells. The cell lysates were
o-, cleaved- and total NPM. Actin was used as an internal control in all the experiments.
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lines (Fig. 2B).
To further understand the molecular mechanisms underlying
HBx-mediated intracellular stabilization of NPM, we checked the
interaction of NPM with caspase-3 in the presence of HBx. Interest-
ingly, we found a marked reduction in their interaction in HBx-
expressing cells as compared to the vector control (Fig. 2C). Further,
we checked if NPM phosphorylation at Thr199 altered the interaction
between caspase-3 and NPM. Intriguingly, inhibition of CDK2-
mediated NPM phosphorylation enhanced the interaction between
the two proteins (Fig. 2D) resulting in the elevated levels of proteo-
lytically cleaved NPM.
3.3. HBx exerts its anti-apoptotic effect by preventing the proteolytic
degradation of NPM
NPM overexpression is known to be associated with abrogation
of apoptosis [10,59]. The C-terminal region of NPM is consideredFig. 3.NPMas amediator of the anti-apoptotic effects ofHBx. IHH cells transfectedwith either ve
Paclitaxel (B) for 24 h. The protein levels of full length as well as cleaved form of NPM were th
etoposide and paclitaxel treatment. GAPDH and actin were used as loading controls, respective
cell lysates were immunoblotted for full length and cleaved form of NPM. Actin was used as an
Relative expression levels of different proteins are shown below each panel. (D) Vector and HBx
of cellswas determinedbyMTT assay. Percent survival of cellswasmeasured and compared to th
three independent experiments. ***, statistically signiﬁcant difference (p b 0.001) as obtained vindispensable for eliciting its anti-apoptotic effects [33] as its cleavage
by activated caspase-3 leads to abrogation of its anti-apoptotic function
[7]. Since viral HBx is well known to confer resistance to genotoxic agents
and interfere with apoptosis in cancer cells [24,42], we wondered if NPM
was one of the mediators of anti-apoptotic activity of HBx. We used two
apoptosis inducers in our experiments, viz., etoposide which is a well-
knownDNA intercalating agent and a topoisomerase II inhibitor, and pac-
litaxel which is a common mitotic inhibitor. Treatment of cells with
etoposide enhanced the proteolytic degradation of NPM as observed by
the increase in levels of cleaved NPM fragment (Fig. 3A,C). However,
there was a marked inhibition in the proteolytic cleavage of NPM upon
HBx expression (Fig. 3A,C). Similarly, HBx also conferred resistance to
proteolytic cleavage of NPM in paclitaxel-treated cells (Fig. 3B). Further,
increase in the viability of HBx-transfected cells even in the presence of
an apoptotic inducer (as observed by MTT assay) conﬁrmed that
etoposide-induced apoptosis could be abated in the presence of HBx
(Fig. 3D). These results strongly suggested that NPM plays a crucial role
in mediating the anti-apoptotic effects of viral HBx.ctor control (V) orHBxexpression plasmidwere treatedwith 50 μMEtoposide (A) or 6 nM
en analyzed by western blotting. Cleavage of PARP was measured as a positive control for
ly. (C) HepG2 and HepG2.2.15 cells were treated with etoposide for 24 h as above and the
internal control. All the blots shown are representative of three independent experiments.
-transfected IHH cells were treatedwith etoposide 24 h after transfection and the viability
e vector-transfecteduntreated cells (taken as 100%). Thedata are shown asmean±S.D. of
ia one-way ANOVA followed by Tukey's HSD test.
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nucleolus
NPM behaves as a nuclear chaperone and translocates several
regulatory proteins such as c-Myc, RPS9 and ARF into the nucleolar
compartment [27,35,37]. It also plays an essential role in the nucleolar
translocation of several viral proteins, thereby making them competent
to alter nucleolar functions upon viral infections [1,53,57,58]. Therefore,
to check whether HBx is associated with NPM in the cellular milieu, the
lysates of vector or HBx-transfected cells were immunoprecipitated
with anti-NPM antibody followed by immunoblotting for HBx. As
shown in Fig. 4A, NPM seemed to speciﬁcally interact with HBx and
the domain of interaction was mapped to the C-terminal region of
NPM as none of its C-terminal deletion mutants (NPM C1, NPM C2
and NPM C3) could immunoprecipitate HBx (Fig. 4B and C).Fig. 4. Direct interaction between NPM and viral HBx. (A) Huh7 cells transfected with HBx a
followed by immuno-blotting (IB) for HBx. (B) To map the NPM domain(s) of interaction, cell
and were subjected to IP using anti-HA antibody followed by IB analysis using anti-FLAG antib
mutants. HomoD: homo-dimerization domain; AD/NLS: acidic domain/nuclear localization s
vitro binding assay of recombinant MBP–HBx and His–NPM. The His-NPM protein was allowed
7). The beads were boiled in 2× Laemmli buffer and the eluted proteins were resolved via SDS
with NPM and HBx antibodies (lanes 8,9). Lanes 1–3 represent puriﬁed recombinant MBP, MBP
pendent experiments.Interestingly, the NPMc mutant, with an extra nuclear export signal,
also interacted with HBx with even higher afﬁnity (Fig. 4B, lane3). The
increased interaction of NPMcmutantwith HBx observed in the present
study might be a result of its unfolded tertiary structure at the C-
terminus which has also been shown to enhance its interaction with
CRM1 nuclear export receptor [21]. Together, these results suggested
that the C-terminal nucleic acid-binding domain of NPM is involved in
its interaction with HBx.
To validate the possibility that the interaction between viral HBx and
cellular NPM was through a direct physical interaction and that it did
not involve other factors, we used puriﬁed recombinant His-tagged
NPM protein to pull down the puriﬁed recombinant MBP–HBx fusion
protein. As shown in Fig. 4D, the puriﬁed His-NPM protein was able to
pull downMBP–HBx fusion protein but failed to pull down recombinant
MBP. Thus, NPM interacted directly with HBx.nd vector control were subjected to immunoprecipitation (IP) using anti-NPM antibody,
s were co-transfected with the indicated FLAG-tagged NPM mutants and HA-tagged HBx,
ody. (C) Schematic representation of the domain structures of WT–NPM and its deletion
ignal; HeteroD: hetero-dimerization domain; NBD: nucleic-acid binding domain. (D) In
to bind to the Ni–NTA beads and incubated with either MBP (lane 6) or MBP–HBx (lane
-PAGE followed by staining with Coomassie brilliant blue (lanes 6,7) or immunoblotting
–HBx and His-NPM proteins respectively. Results shown are representative of three inde-
Fig. 5. Sub-cellular localization of viral HBx upon NPM over-expression. (A) Huh7 cells co-transfected either with FLAG tagged wild-type NPM (WT-NPM) or its mutants along with HA
tagged-HBx were examined by confocal immunoﬂuorescence microscopy after staining with antibodies to FLAG and HA. Fluorescent Alexa Fluor 488 and 594 conjugated secondary an-
tibodies were used for detection of FLAG-tagged NPM (green) and HA–HBx (red), respectively. Nucleus stained with DAPI has been shown in blue. (B) Immunoﬂuorescence assay of
HepG2.2.15 cells after staining for endogenous NPM (green) and viral HBx (red) as above. The images shown are representative of three independent experiments. (C) Summary table
showing the localization of HBx in the presence of WT–NPM and its C-terminal deletion mutants.
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the sub-cellular distribution of HBx using immunoﬂuorescence assay.
HBx was found to localize mainly in the cytoplasmic compartment.
However, a fraction of it was also present in the nuclear as well as
nucleolar regions (Supplemental Fig. S4). Overexpression of wild-type
NPM facilitated the translocation of HBx into the nucleolar compart-
ment (Fig. 5A, top panel). Expectedly, co-expression of HBx with the
C-terminal deletion mutants of NPM that did not interact with HBx,
failed to translocate cytoplasmic HBx into the nucleolus (Fig. 5A). Inter-
estingly, HBx co-localized in the cytoplasmic compartment with the
NPMc mutant (Fig. 5A, bottom panel), which has an extra NES motif
and localizes in the cytoplasm [31]. Similarly, the HBx-expressing
HepG2.2.15 cells also showed co-localization of HBx and endogenous
NPM in the nucleolus (Fig. 5B). Together these results suggested a
novel role of NPM in the nucleolar translocation of HBx. Fig. 5C summa-
rizes the localization of HBx with respect to NPM and its deletion
mutants.
3.5. HBx–NPM interaction enhances rDNA transcription in the nucleolus
The physiological relevance of HBx–NPM interaction and the associ-
ated nucleolar localization of HBx was studied vis-à-vis ribosomal DNA
transcription. Co-expression of HBx and wild-type NPM led to a signiﬁ-
cant increase (p b 0.001) in the RNA polymerase I-dependent luciferase
reporter activity (Fig. 6A). The reporter assay results were substantiated
by a signiﬁcant elevation in the levels of rRNA transcripts (p b 0.001)
under these conditions (Fig. 6B). In contrast, co-expression of HBx
with the NPM deletion mutants did not stimulate the rDNA promoter
(Fig. 6A,B). Note that the apparent increase in luciferase activity in
cells co-expressing NPM C1 mutant and HBx, over HBx-transfected
cells was found to be statistically non-signiﬁcant (p b 0.117). Similar re-
sults were obtained when rRNA levels were normalized using actin as
an internal control (Supplemental Fig. S5). Thus, HBx and NPM seem
to cooperate in stimulating rDNA promoter which may have a role in
the pathophysiology of HBV-mediated HCC.
3.6. HBx facilitates the recruitment of RNA polymerase I transcription ma-
chinery on the rDNA promoter in an NPM-dependent manner
To further substantiate the enhancement of rDNA transcription
in the presence of HBx, we analyzed the recruitment of different
transcription factors to their cognate response elements on the rDNAFig. 6. NPM-dependent stimulation of rDNA promoter in the presence of HBx. (A) Huh7 cells w
vectors for HBx, FLAG-NPM and its C-terminal deletionmutants NPM C1, NPM C2 and NPM C3 a
for luciferase activity. The graph represents the relative luciferase activity after normalization w
with FLAG-NPM or its C-terminal deletion mutant NPM C3 as indicated. Total RNA was extract
speciﬁc primers (Supplemental Table S1). The transcripts for acidic ribosomal phosphorprotein
dent experiments. *, **, ***, represents statistically signiﬁcant difference at p b 0.05, p b 0.01 anpromoter. As revealed by chromatin immunoprecipitation (ChIP)
assays, a signiﬁcant two-fold increase in the enrichment of c-Myc and
UBF was observed in the presence of HBx as compared to the vector
control (Fig. 7A,B). The binding of c-Myc and UBF was enhanced by
many folds upon co-expression of wild-type NPM and HBx. However,
no change in the promoter occupancy of these transcription factors
was observed in the presence of NPM C3 mutant and HBx with respect
to the vector control. Interestingly, it was found to be even lower as
compared to cells expressing HBx alone, effectively reversing the effects
elicited by HBx. Since NPM is functional as an oligomer (often as a
pentamer), the expression of the dominant negative NPM C3 mutant
[3,34] can result in its oligomerization with the endogenous NPM
leading to the formation of non-functional NPM C3-NPM oligomers.
Therefore, the simultaneous expression of HBx with NPM C3 mutant
might prevent the utilization of endogenous NPM by HBx thereby pre-
cluding HBx from exerting its effects on the recruitment of c-Myc and
UBF onto the rDNA promoter (Fig. 7). Thus, these results supported
our earlier observations on the role of NPM in HBx-mediated activation
of rDNA transcription.
UBF along with other transcription factors such as c-Myc, is well
known to promote the recruitment of RNA polymerase I and thus
determine the relative proportion of active and silent rRNA genes [11].
Therefore, we next checked the effect of HBx expression on the
occupancy of RNA polymerase I on the rDNA promoter. Interestingly,
the RNA Pol I occupancy was enhanced by nearly fourfolds in HBx
transfected Huh7 cells as compared to the vector control (Fig. 7C).
Expectedly, co-expression of wild-type NPM and HBx showed a further
increase in Pol I bindingwhereas no increase in its promoter occupancy
was observed when dominant negative NPM C3 mutant was
co-expressed with HBx (Fig. 7C). Interestingly, the knockdown of
HBx expression by speciﬁc shRNA construct (XE), led to a pronounced
decrease in the rDNA promoter occupancy of transcription factors
such as c-Myc along with RNA Pol I (Fig. 7D). Together, these results
suggested thatNPM is an important cellular partner of viralHBx in stim-
ulating rDNA promoter activity and hence Pol I transcription.
3.7. HBx promotes rDNA transcription by enhancing NPM acetylation and
affecting nucleosome occupancy
We next sought to further delineate the molecular mechanism of
enhanced recruitment of Pol I transcription machinery on the rDNA
promoter in the presence of HBx. Previously, it has been found thatere transfected with rDNA-pGL3 luciferase reporter construct along with the expression
s indicated. Cells were harvested 48 h after transfection and the cell extracts were assayed
ith the total protein. (B) Cells were transfected with either HBx alone or in combination
ed after 48 h and was used to measure the levels of 5.8S and 18S rRNA by RT-qPCR using
P0were used as an internal control. The data are shown asmean± S.D. of three indepen-
d p b 0.001 respectively as obtained via one-way ANOVA followed by Tukey's HSD test.
Fig. 7. Effect of HBx on the recruitment of RNA polymerase I transcription machinery on the rDNA promoter. Huh7 cells transfected with vector control or expression plasmids for HBx,
WT–NPM, and NPM C3 mutant either alone or in combination as indicated were grown in serum-free medium for 60 h. The cells were released by addition of complete medium and
harvested after 9 h for analyzing the promoter occupancy of the following factors: c-Myc (A), Upstream Binding Factor or UBF (B) and RNA polymerase I (C). (D) Cells were transfected
with vector control or HBx expression plasmid either alone or in combination with HBx-speciﬁc shRNA (XE) and analyzed for the rDNA promoter occupancy of c-Myc and RNA Pol I by
ChIP-qPCR as above. The lower panel shows the expression of HBx under these conditions. (E) Cells transfectedwith either vector control or HBx expression plasmidwere harvested after
48 h of transfection and the cell lysates were immunoprecipitated with anti-NPM antibody followed by western blotting for acetylated NPM using anti-acetyl Lysine antibody. Actin was
used as an internal control. The fold change in levels of acetylated NPM (acNPM) and NPM are shown below the corresponding panels. The blots shown are representative of three inde-
pendent experiments. (F) Huh7 cells were transfectedwith vector control or expression plasmids for HBx,WT–NPM, and NPMC3mutant either alone or in combination as indicated and
were analyzed for the relative promoter occupancy of total histone H4, acetylated histoneH4 (acH4) and acetylated histoneH3 (acH3) over that of IgG control by ChIP-qPCR using speciﬁc
primers (Supplemental Table 1). The data are shown as mean ± S.D. of three independent experiments. *, **, ***, represents statistically signiﬁcant difference at p b 0.05, p b 0.01 and
p b 0.001, respectively, as obtained via one-way ANOVA followed by Tukey's HSD test.
1791R. Ahuja et al. / Biochimica et Biophysica Acta 1853 (2015) 1783–1795alteration of histone chaperone activity of NPM, for example, by acetyla-
tion is associated with its increased afﬁnity for acetylated histones
which in turn triggers nucleosomal disassembly and activation of
transcription [51]. Therefore, to understand the mechanism of HBx-mediated enhanced rDNA transcription, we checked the acetylation
status of NPM in the presence of HBx. HBx expression resulted in a
signiﬁcant (~2 fold) increase in the levels of acetylated NPM (Fig. 7E).
Also, there was a marked decline in the recruitment of acetylated
1792 R. Ahuja et al. / Biochimica et Biophysica Acta 1853 (2015) 1783–1795histone H4 (acH4) on the rDNA promoter in HBx-expressing
HepG2.2.15 cells but not inHepG2 cells (Supplemental Fig. S6). Notably,
the occupancy of acH4, acH3 and total histoneH4 also decreased in cells
expressing either HBx or HBx along with NPM (Fig. 7F). Interestingly,
the histone occupancy on the rDNA promoter was relatively higher
when HBx was co-expressed with NPM C3 mutant (Fig. 7F). Thus,
HBx seems to enhance rDNA transcription via a novel regulatory
mechanism involving the depletion of histones resulting from increased
NPM acetylation.
3.8. HBx involves nucleophosmin to promote ribosome biogenesis, cell
proliferation and cell transformation
Since rDNA transcription positively correlates with ribosome
biogenesis, we next analyzed the ribosome proﬁle of cells upon HBx
expression (either alone or in combination with NPM and its mutant
NPM C3). A signiﬁcant increase (p b 0.01; n = 3) in the amount of ma-
ture 80S ribosomes was observed in HBx and NPM co-transfected cells
as compared to the control cells (Fig. 8A and B). Further, the amount
of ribosomes was drastically reduced when HBx was co-expressed
with the NPM C3 mutant. These results signify the importance of NPM
in HBx-mediated enhanced ribosome biogenesis.
Further, to investigate whether the observed enhanced ribosome
biogenesis had a bearing on cellular proliferation, we analyzed the pro-
liferation rate by measuring the incorporation of bromodeoxyuridine
(BrdU) in the cells under these conditions. The percentage of BrdU
positive cells was signiﬁcantly higher in cells transfected with HBx
either alone or in combination with wild-type NPM (Fig. 8C). However,
there was a marked reduction in the BrdU positive cells when HBx
was co-expressed along with the dominant negative NPM C3
mutant. To test whether the enhanced proliferation was also linked
to cellular transformation, we performed soft agar colony formation
assay to evaluate the growth-promoting role of NPM in the presence
of HBx. As shown in Fig. 8D, IHH cells co-transfected with HBx and
NPM produced signiﬁcantly higher number of colonies as compared
to the vector control. In contrast, co-expression of HBx with domi-
nant negative NPM C3mutant did not induce cellular transformation
of these cells. Taken together, these results signify the pivotal role
played by the host protein NPM in promoting the oncogenic effects
of viral oncoprotein HBx.
4. Discussion
Nucleolus, earlier considered as an exclusive factory of ribosome bio-
genesis, has been recently implicated as a sensor of cellular and external
stresses due to its involvement in several signaling pathways. Most of
these functions are attributed to the major nucleolar proteins viz., NPM,
nucleolin and ﬁbrillarin which constitute almost 20% of the total nucleo-
lar proteome. Ribosome biogenesis, being the most energy consuming
process of the cell, is under an efﬁcient regulation and thus is tightly
linked to cellular proliferation. Indeed, rDNA transcription, one of the
major events of ribosome biogenesis, is at the center of the complex net-
work linking multiple stress signals with cell growth and proliferation.
Several oncogenes are known to potentiate rRNA synthesis resulting inFig. 8. Interference in ribosome biogenesis, cell proliferation and transformation by NPM mu
transfectedwith expression plasmids for vector control, HBx,WT–NPM and dominant negative
collectedwasmeasured at 254 nm and plotted. Peaks respresenting 80S ribosomes and polyrib
tative image is shown. (B) The relative fold change in the absorbance corresponding to thematu
(n=3)was plotted. The data are shown asmean± S.D. of three independent experiments. *, **
way ANOVA followed by Tukey's HSD test. (C) Huh7 cells transfectedwith vector control, HBx,
nized in the early S-phase and labeledwith BrdU.Nucleiwere stainedwithDAPI (blue) and FITC
Scale bar represents 50 μm. Percentage of BrdU positive cells in each sample was determined a
pendent experiments. ***, statistically signiﬁcant difference at p b 0.001 as obtained via one-w
plasmids as in panel (C) and grown in soft agar for 25 days in a humidiﬁed chamber with 1
under a bright ﬁeld microscope. Two random images from each sample are shown. Scale bar
a ×10 objective and number of foci formed in each were counted and their mean (n = 3) wa
obtained via one-way ANOVA followed by Tukey's HSD test.enhanced ribosome biogenesis, which is a pre-requisite of uncontrolled
cellular proliferation. Recently, we have shown that the HBx oncoprotein
of HBV can cooperate with the cellular oncogene c-Myc to enhance the
rDNA promoter activity [49]. Not surprisingly, HBx is widely acknowl-
edged to be involved in the development of HCC. However, the mecha-
nistic link between HBx-mediated cellular transformation and the
stimulation of rDNA transcription is rather feeble.
Progression of HCC is associated with an escalated nucleolar
functioning and nucleolar hypertrophy, a state characterized by the
presence of numerous larger nucleoli [56]. The proliferating cells have
been shown to have higher levels of NPM as compared to resting or
quiescent cells suggesting the mitogenic potential of NPM [15]. In
agreement with these observations, increased NPM expression corre-
lates well with tumor progression in HCC [61]. Further, the proteomic
analysis of the HBx transfected human hepatocytes has revealed the
upregulation of several nucleolar proteins including NPM [36]. NPM
is known to actively contribute towards some speciﬁc functions dur-
ing different phases of the cell cycle including ribosome assembly (in
the S-phase) and regulation of centrosome duplication cycle (in the
M-phase) [37,44]. Besides, it has previously been shown that an
enhanced expression of NPM leads to increased c-Myc mediated
rDNA gene transcription while reduction in its endogenous levels
fail to stimulate c-Myc dependent rRNA synthesis [35]. In this con-
text, our observation that the expression of NPM is further enhanced
during S phase in the presence of HBx (Fig. 1D) gains signiﬁcance and
indicates towards increased ribosome biogenesis under these
conditions [49].
Many viral oncoproteins use a common strategy either to stabilize
cellular oncoproteins [5] or destabilize tumor suppressor proteins by
tinkering with their phosphorylation [19]via modulating the activity
of various protein kinases and phosphatases involved in cell cycle
regulation. For instance, the activity of CDK2 is potentiated in the
presence of HBx [41]. In our study, HBx-induced CDK2 activity increased
the phosphorylation of NPM at Thr199 (Fig. 2) which correlated well
with its increased intracellular stability. While NPM phosphorylation
at Thr199 has been previously reported to regulate centrosome duplica-
tion [55], the present study seems to suggest its role in conferring
intracellular stability to NPM by preventing its caspase-3 mediated
cleavage in HBx-expressing cells. Enhanced phosphorylation of NPM
at Thr199 by CDK2 kinase in the presence of HBx seemed to play a crucial
role in preventing its interactionwith caspase-3, leading to the accumu-
lation of intracellular NPM. Furthermore, during apoptosis, the activa-
tion of caspase cascade results in the proteolytic cleavage of NPM [7].
Since NPM is essential for maintaining cell viability, its cleavage may re-
sult in cell deathmajorly due to reduction in ribosomebiogenesis [8]. Our
results have shown that HBx can prevent NPM cleavage even in the
presence of apoptotic inducers like etoposide and paclitaxel (Fig. 3).
Previously, we have shown that HBx oncoprotein can inhibit apoptosis
by activating the Akt signaling-pathway [25]. Further, Akt and other
cellular oncoproteins such as Ras have also been shown to inhibit
apoptosis by preventing NPM degradation ([7,33]). Therefore, inhibition
of proteolytic cleavage of NPM in the HBx-expressing cells could be yet
another mechanism of derailing apoptosis and promoting cellular
transformation.tant C3 in HBx-expressing cells. (A) Representative polysomal proﬁles from Huh7 cells
NPMC3mutant either alone or in indicated combinations. The absorbance of the fractions
osomes (or polysomes) are indicated. The experimentwas repeated thrice and a represen-
re 80S ribosomal fractionwas calculated as compared to the vector control and theirmean
, statistically signiﬁcant difference at p b 0.05 and p b 0.01, respectively as obtained via one-
WT–NPM, and NPMC3mutant either alone or in combinations as indicatedwere synchro-
-conjugatedgoat anti-mouse antibodywasused for visualizing BrdU incorporation (green).
nd the mean was plotted. The data (lower panel) are shown as mean± S.D. of three inde-
ay ANOVA followed by Tukey's HSD test. (D) IHH cells were transfected with expression
0% CO2 at 37 °C. The colonies obtained were stained using crystal violet and visualized
represents 20 μm. Fifteen random bright ﬁeld images of each sample were captured with
s plotted as bar graph (lower panel). ***, statistically signiﬁcant difference at p b 0.001 as
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lar proteins and affect their stability and myriad of associated functions
including apoptosis, cell cycle regulation, DNA replication and repair,
stress response, RNA processing and most importantly ribosome biogen-
esis [14]. The present study showed that cellular NPM interacted with
viral HBx through its C-terminus (Fig. 4) which is required for nucleic
acid binding [15] and hence is essential for the chaperoning and RNA
processing functions. NPM is primarily localized in the nucleolus due
to the presence of a nucleolar localization signal at its C-terminus. Our
observation that NPM-HBx interaction led to the nucleolar translocation
of HBx suggests the nucleolar chaperoning of HBx by NPM (Fig. 5).
Since HBx does not possess a nucleolar localization signal, its presence
in the nucleolus suggested some important functional implications.
Indeed, we observed a major surge in rDNA transcription upon HBx
expression. This effect was speciﬁc and was mediated by NPM as the
NPM deletion mutants that did not interact with HBx failed to upregu-
late the transcriptional activity of RNA polymerase I (Fig. 6). Thus, our
results, for the ﬁrst time, implicate NPM inHBx-mediated enhancement
of rDNA transcription.
Modulation of chromatin architecture is an important means of
transcriptional regulation. NPM, like other histone chaperones,
plays an important role in assembly and disassembly of nucleosomes
and hence is crucial for the regulation of gene expression. Increase in
NPM levels per se has no effect on nucleosome occupancy. However,
its post-translational modiﬁcations, primarily acetylation, alter its
afﬁnity towards histones [43,51]. Acetylation of NPM increases its
afﬁnity towards acetylated histones leading to the depletion of
histones from the chromatin, thereby promoting transcription [51].
Hence, the enhanced acetylation of NPM in HBx-expressing cells
and a consequent decrease in the histone occupancy on the rDNA
promoter observed in the present study (Fig. 7) provides a mecha-
nistic link into the NPM-dependent and HBx-mediated stimulation
of the rDNA promoter. It is well known that a transcriptionally
competent chromatin state shows relatively lower nucleosome
occupancy in order to facilitate the recruitment of transcription
machinery. Not surprisingly, a decreased histone occupancy on the
rDNA promoter was associated with increased recruitment of RNA
polymerase I transcription machinery onto the rDNA promoter
(Fig. 7). Apart from NPM, rDNA transcriptional activation involves
the synergistic action of various cellular factors such as c-Myc and
UBF among others [13]. Therefore, while NPM acetylation and the as-
sociated histone depletion appear to play a major role in HBx-
mediated rDNA activation, the simultaneous involvement of other
mechanisms cannot be ruled out.
Increased rDNA transcription correlates well with enhanced ribo-
some biogenesis in actively proliferating and transformed cells [40].
We have shown that NPM plays a major role in driving HBx-
mediated cell proliferation as evident from the enhanced production
of mature 80S ribosomes and increased rate of BrdU incorporation in
cells co-expressing HBx and wild-type NPM (Fig. 8). Also, the ability
of these cells to form larger number of colonies in soft agar as com-
pared to cells co-expressing HBx and the non-interacting dominant
negative NPM mutant further signiﬁes the role of NPM in mediating
the oncogenic potential of HBx (Fig. 8). Thus, NPM appears to be a
major player in the HBx-driven HCC progression and tumorigenesis.
These results further strengthen the notion that viral oncoproteins
often hijack nucleolar functions in order to support the growth and
proliferation of transformed cells [20].
4.1. Conclusions
In conclusion, the present study delineates a novel mechanism for
HBx-mediated enhanced rDNA transcription and cellular transforma-
tion. The functional interaction of viral oncoprotein HBx with a major
nucleolar phosphoprotein NPM leading to the stabilization of NPM
explains a plausible means of the anti-apoptotic action of HBx duringHCC progression. Further, translocation of HBx in the nucleolus together
with increased acetylation of NPM in HBx-expressing cells could have
important bearing on enhanced rDNA transcription apparently via
accelerated chromatin remodeling near the rDNA promoter. The indis-
pensable nature of NPM in rRNA synthesis and its targeting by HBx to
promote cell survival makes it beneﬁcial for the virus and helps in the
maintenance and progression of the cancer phenotype.
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